Essais liés2clinical trials
VilleXi'anlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03963232

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Nerandomilast Myopathies Phase 3 NCT07789015 VERANDA™-IIM — A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies NOT_YET_RECRUITING
Galcanezumab Migraine Phase 3 NCT03963232 PERSIST — A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine COMPLETED